People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Convelo Therapeutics, Inc. | — | Pharma | Series A | $12.8M | $113.3M | 2017 |
| NanoScale Corp | — | Other Technology | Seed | $1.5M | $52.0M | 2011 |
Bill Sanford at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bill Sanford on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Trevor Jones | 1 | 3 |
| James Dietz | 1 | 2 |
| Drew Adams | 1 | 2 |
| Steven Landau | 1 | 2 |
| Terry King | 1 | 1 |
| Joseph Downey | 1 | 1 |
| Ronald Richard | 1 | 1 |
| Paul Tesar | 1 | 1 |
| Derrick Rossi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.